225 related articles for article (PubMed ID: 1923519)
1. Imbalanced expression of cellular nuclear oncogenes caused by v-sis/PDGF-2.
Sonobe MH; Bravo R; Armelin MS
Oncogene; 1991 Sep; 6(9):1531-7. PubMed ID: 1923519
[TBL] [Abstract][Full Text] [Related]
2. Transformation of diploid human fibroblasts by DNA transfection with the v-sis oncogene.
Fry DG; Milam LD; Maher VM; McCormick JJ
J Cell Physiol; 1986 Aug; 128(2):313-21. PubMed ID: 3015989
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells.
Potapova O; Fakhrai H; Baird S; Mercola D
Cancer Res; 1996 Jan; 56(2):280-6. PubMed ID: 8542581
[TBL] [Abstract][Full Text] [Related]
4. Suppression of v-sis-dependent transformation by the transcription factor, Egr-1.
Huang RP; Darland T; Okamura D; Mercola D; Adamson ED
Oncogene; 1994 May; 9(5):1367-77. PubMed ID: 8152797
[TBL] [Abstract][Full Text] [Related]
5. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR
Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742
[TBL] [Abstract][Full Text] [Related]
6. The sis gene and PDGF.
Williams LT
Cancer Surv; 1986; 5(2):233-41. PubMed ID: 3536086
[TBL] [Abstract][Full Text] [Related]
7. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
[TBL] [Abstract][Full Text] [Related]
8. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
9. Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutant.
Rapp UR; Troppmair J; Beck T; Birrer MJ
Oncogene; 1994 Dec; 9(12):3493-8. PubMed ID: 7970709
[TBL] [Abstract][Full Text] [Related]
10. V-sis gene (SSV) is expressed transiently and independently of v-gag (SSAV) after infection of fibroblasts with SSV/SSAV.
Schätzl HM; von der Helm K
Oncogene; 1989 Sep; 4(9):1095-101. PubMed ID: 2550873
[TBL] [Abstract][Full Text] [Related]
11. T antigens' role in polyomavirus transformation: c-myc but not c-fos or c-jun expression is a target for middle T.
Rameh LE; Armelin MC
Oncogene; 1991 Jun; 6(6):1049-56. PubMed ID: 1648700
[TBL] [Abstract][Full Text] [Related]
12. Rapid, complete and reversible transformation by v-sis precedes irreversible transformation.
Mercola D; Carpenter PM; Grover-Bardwick A; Mercola M
Oncogene; 1992 Sep; 7(9):1793-803. PubMed ID: 1501889
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
Morello D; Lavenu A; Babinet C
Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of PC-12 cell differentiation by the immediate early gene fra-1.
Ito E; Sweterlitsch LA; Tran PB; Rauscher FJ; Narayanan R
Oncogene; 1990 Dec; 5(12):1755-60. PubMed ID: 2178237
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of PDGF-induced c-jun and c-fos expression by a tyrosine protein kinase inhibitor.
Zwiller J; Sassone-Corsi P; Kakazu K; Boynton AL
Oncogene; 1991 Feb; 6(2):219-21. PubMed ID: 1900355
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle dependent growth factor regulation of gene expression.
Morgan CJ; Pledger WJ
J Cell Physiol; 1989 Dec; 141(3):535-42. PubMed ID: 2512304
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative.
Buchdunger E; Zimmermann J; Mett H; Meyer T; Müller M; Druker BJ; Lydon NB
Cancer Res; 1996 Jan; 56(1):100-4. PubMed ID: 8548747
[TBL] [Abstract][Full Text] [Related]
18. A high-molecular-weight PDGF-like factor secreted by v-sis transformed cells leads to growth stimulation and transformation.
Klein R; Thiel HJ
Oncogene Res; 1988 May; 2(4):311-24. PubMed ID: 2840622
[TBL] [Abstract][Full Text] [Related]
19. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
Su ZZ; Yemul S; Stein CA; Fisher PB
Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
[TBL] [Abstract][Full Text] [Related]
20. Platelet-derived growth factor: roles in normal and v-sis transformed cells.
Deuel TF; Kimura A; Maehama S; Tong BD
Cancer Surv; 1985; 4(4):633-53. PubMed ID: 2824043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
